Metastatic HPV-16 Positive Squamous Cell Anal Cancer
1 clinical trials · Condition
◉ Watch Metastatic HPV-16 Positive Squamous Cell Anal Cancer
| Record | Firm | Date |
|---|---|---|
| Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab (NCT04536922) | National Cancer Institute (NCI) | 2021-01-27 |
Track Metastatic HPV-16 Positive Squamous Cell Anal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.